DEF 14A: Western Acquisition Ventures Corp. Seeks Extension to Complete Business Combination with Cycurion, Inc.

Sentiment:

Proxy Statement


Western Acquisition Ventures Corp. is seeking stockholder approval to extend the deadline for completing its business combination with Cycurion, Inc. by three months, from April 11, 2024, to July 11, 2024.

Delay expectedThe company is seeking an extension due to delays in finalizing the proposed business combination with Cycurion, Inc.

Summary

  • Western Acquisition Ventures Corp. is holding a Special Meeting of Stockholders on April 10, 2024, to vote on proposals to extend the deadline for completing a business combination.
  • The company seeks to amend its Certificate of Incorporation and Trust Agreement to allow for a three-month extension, from April 11, 2024, to July 11, 2024.
  • The primary reason for the extension is to allow more time to finalize the proposed business combination with Cycurion, Inc., including completing the registration statement and holding a special meeting to approve the transaction.
  • If the proposals are approved, the company will have until July 11, 2024, to complete the business combination.
  • If the proposals are not approved, the company will be forced to liquidate, returning the funds in the trust account to public stockholders.
  • Public stockholders have the right to redeem their shares for a pro rata portion of the trust account, regardless of how they vote on the extension proposals.
  • As of January 31, 2024, the trust account held approximately $2,966,591.
  • The company's sponsor and financial advisor, A.G.P., who collectively hold a majority of the outstanding shares, have agreed to vote in favor of the proposals, ensuring their approval.
  • The original Merger Agreement provided that the Company would acquire all of the outstanding equity interests of Cycurion in exchange for an aggregate of 9,500,000 shares of the Company Common Stock, par value $0.0001 per share (the Merger Consideration Shares).
  • The number of Merger Consideration Shares and the structure of the transaction is being revised to give effect to additional financing undertaken by Cycurion for operations due to the delay in completing the Business Company and additional funds needed by the Company to close the Business Combination.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document outlines the need for an extension to complete a business combination, which is a common occurrence for SPACs. While there are risks associated with the extension and potential liquidation, the company is taking steps to address these challenges.

Positives

  • Approval of the extension allows the company more time to complete the proposed business combination with Cycurion, Inc., potentially providing stockholders with the opportunity to benefit from the merger.
  • Stockholders retain the right to vote on the proposed business combination and redeem their shares if they disapprove of the transaction.
  • The redemption price per share is estimated to be approximately $10.51 if the extension is approved.

Negatives

  • If the extension is not approved, the company will be forced to liquidate, and the warrants will become worthless.
  • Redemption of shares by public stockholders will decrease the amount in the trust account.
  • The sponsor, officers, and directors have interests that may be different from those of public stockholders, potentially leading to a business combination that is not favorable to public stockholders.

Risks

  • The company may not be able to complete the proposed business combination even if the extension is approved.
  • The proposed business combination may be subject to U.S. foreign investment regulations and review by CFIUS, which could delay or prevent the transaction.
  • The company cannot assure stockholders that they will be able to sell their shares of the Companys common stock in the open market, even if the market price per share is higher than the redemption price stated above, as there may not be sufficient liquidity in its securities when such stockholders wish to sell their shares.

Future Outlook

The company intends to continue working towards completing the proposed business combination with Cycurion, Inc. If the extension is approved, the company will have until July 11, 2024, to complete the transaction. If the business combination is not completed by then, the company will liquidate.

Management Comments

  • The Board has determined that it is in the best interests of our stockholders to extend the date that the Company has to consummate the Proposed Business Combination.
  • After careful consideration of all relevant factors, the board of directors has determined that each of the proposals are advisable and recommends that you vote or give instruction to vote FOR such proposals.

Industry Context

This announcement is typical for SPACs approaching their deadline to complete a business combination. Seeking extensions is a common strategy to provide more time to finalize deals, especially when facing regulatory hurdles or financing challenges.

Comparison to Industry Standards

  • Many SPACs seek extensions to complete their business combinations, especially in challenging market conditions.
  • The redemption rate of public shares is a key metric to watch, as high redemption rates can impact the amount of capital available for the business combination.
  • The proposed $100 deposit into the trust account for the extension is a nominal amount, which is not uncommon for SPAC extensions.

Stakeholder Impact

  • Stockholders have the right to vote on the extension proposals and redeem their shares.
  • If the business combination is completed, stockholders may benefit from the potential growth of the combined company.
  • If the company liquidates, stockholders will receive a pro rata portion of the trust account, but warrants will become worthless.

Next Steps

  • Stockholders will vote on the extension proposals at the Special Meeting on April 10, 2024.
  • If the proposals are approved, the company will continue working towards completing the business combination with Cycurion, Inc.
  • If the proposals are not approved, the company will liquidate.

Key Dates

DateDescription
January 11, 2022Date of the Company's IPO and Trust Agreement.
November 21, 2022Date the Company entered into an Agreement and Plan of Merger with Cycurion, Inc.
March 27, 2024Record date for determining stockholders entitled to vote at the Special Meeting.
April 3, 2024Date of the Proxy Statement.
April 8, 2024Deadline for stockholders to tender shares to exercise redemption rights.
April 10, 2024Date of the Special Meeting of Stockholders.
April 11, 2024Original deadline for the Company to complete a business combination.
July 11, 2024Proposed extended deadline for the Company to complete a business combination.

Keywords

business combination, special purpose acquisition company, SPAC, extension, redemption, proxy statement, merger, Cycurion, liquidation, trust account

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.